Notable
TRADITiONAL · Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients
Recruitment opened
OrphalanPhase 3 NCT07465718 Registry history of NCT07465718 on ClinicalTrials.gov (opens the registry)
Updated